RecruitingNCT01205815

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment


Sponsor

Vanderbilt-Ingram Cancer Center

Enrollment

3,000 participants

Start Date

Jun 3, 2010

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Pathologically-proven diagnosis of melanoma.
  • Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible.

Exclusion Criteria2

  • Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol.
  • Any patient unable or unwilling to provide consent.

Interventions

OTHERTissue and blood collection

Tissue will be obtained from a previous biopsy if available, or if unavailable, tissue will be collected from a scheduled biopsy. About3-4 teaspoons of blood will be collected.


Locations(1)

Vanderbitl-Ingram Cancer Center

Nashville, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01205815


Related Trials